быстрая доставка ~4 недели
Размер
- 1 mg
- 100 μg
Active Recombinant SARS-CoV-2 Nucleocapsid Protein (RP01264LQ)
- Описание
-
Overview
Product name Active Recombinant SARS-CoV-2 Nucleocapsid Protein Catalog No. RP01264LQ Description Recombinant SARS-CoV-2(2019-nCoV) Nucleocapsid Protein is produced by E. coli expression system. The target protein is expressed with sequence (Met1-Ala419) of SARS-COV-2(2019-nCoV) Nucleocapsid (Accession #QHD43423.2) fused with an 6×His tag at the N-terminus. Bio-Activity 1.Measured by its binding ability in a functional ELISA. Immobilized Recombinant SARS-CoV-2 Nucleocapsid at 2 μg/mL (100 μL/well) can bind Anti-Nucleocapsid antibody with a linear range of 0.12-1.64 ng/mL. 2.Measured by its binding ability in a functional ELISA. Immobilized Recombinant SARS-CoV-2 envelope Protein at 2 μg/mL (100 μL/well) can bind Recombinant SARS-CoV-2 Nucleocapsid protein, the EC50 of Recombinant SARS-CoV-2 Nucleocapsid protein is 41.10 ng/mL. Purity > 95% by SDS-PAGE;> 95% by HPLC. Endotoxin < 1.0 EU/μg of the protein by LAL method. Formulation Supplied as a 0.22 μm filtered solution in 20mM Tris, 500mM NaCl, 0.1mM EDTA, 10% glycerol, pH8.0.Contact us for customized product form or formulation. Species SARS-CoV-2 Calculated MW 49.4kDa Product information
Synonym Nucleocapsid protein; NP; Nucleoprotein; cov np; Protein N; COVID-19 Expression Host E. coli Tag N-His Gene ID Usage guide
Storage This product is stable at ≤ -70°C for up to 1 year from the date of receipt.
For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature.* For research use only. Not for therapeutic or diagnostic purposes.
Product Protocols